VIE News and Press, Viela Bio Inc. From 02/25/21

-No new safety signals were identified with prolonged inebilizumab treatment and inebilizumab-mediated B-cell depletion- -UPLIZNA was shown to be safe and effective in patients with previous exposure to off-label therapy- GAITHERSBURG, Md., Feb. 25, 2021 (GLOBE N...

GAITHERSBURG, Md., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for patients suffering from autoimmune and severe inflammatory diseases, today announced it will report...

Shares of Viela Bio (NASDAQ: VIE) were soaring Monday morning after it was announced that the biopharmaceutical company will soon be acquired by Horizon Therapeutics (NASDAQ: HZNP) . As of 11:27 a.m. EST, shares of Viela Bio were up by 52.5%. Horizon Therapeutics will ac...

Gainers: Comstock Mining (LODE) +125%.Viela Bio (VIE) +53%.Dynavax Technologies (DVAX) +47%.Avino Silver & Gold Mines (ASM) +46%.Ferroglobe (GSM) +43%.Alithya (ALYA) +39%.Tuscan Holdings (THCB) +35%.Sundial Growers (SNDL) +32%.Inovio Pharmaceuticals (INO) +31%.Bio...

Horizon Therapeutics plc (NASDAQ: HZNP) and Viela Bio, Inc. (NASDAQ: VIE) have entered into a definitive agreement where Horizon will acquire all issues and outstanding shares of Vielo Bio common stock for USD 53 per share in cash or a fully diluted equity value of USD...

Alithya Group (ALYA) +237%.Avino Silver & Gold Mines (ASM) +132%.Comstock Mining (LODE) +73%.Viela Bio (VIE) +53%.Phunware (PHUN) +50%.Tuscan Holdings Corp. (THCB) +45% as Microvast go public through a merger with the company.First Majestic Silver (AG) +37%.Borqs Technologies (BRQS) ...

Horizon Therapeutics (HZNP) and Viela Bio (VIE), up 24% premarket ink agreement under which Horizon will acquire all of the issued and outstanding shares of Viela Bio common stock for $53.00/share in cash, representing a fully diluted equity value of ~$3.05B.The transaction is expec...

- Conference Call Today at 8 a.m. EST to Discuss Transaction - - Provides TEPEZZA® (teprotumumab-trbw) Supply Update; Submitted Prior Approval Supplement to FDA to Support Increased Scale Production of TEPEZZA - Horizon Therapeutics plc (Nasdaq: HZNP) and Viela ...

Halvorsen's 13F portfolio value increased from $23.14B to $27.68B. The number of positions increased 71 to 86. Viking Global increased Microsoft, Mecadolibre, and CME Group while reducing Amazon.com and dropping Uber Technologies & JD.com. The top three positions are Microsoft...

Viela Bio is an AstraZeneca-MedImmune spinoff. It has one approved drug and a long tailed pipeline. Their next catalyst is three to four years away. For further details see: Viela Bio: Startup With A Head Start